ABACUS-2

• Research type

  Research Study

• Full title

  A phase II study of neoadjuvant immune checkpoint inhibitors in urothelial cancer

• IRAS ID

  1003489

• Contact name

  Thomas Powles

• Contact email

  bci-abacus2@qmul.ac.uk

• Eudract number

  2019-004628-39

• ISRCTN Number

  ISRCTN22771691

• REC name

  HSC REC A

• REC reference

  20/NI/0148

• Date of REC Opinion

  16 Dec 2020

• REC opinion

  Further Information Favourable Opinion